Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain dividend payments | A primary condition in United-Guardian Inc's published investment case. The stated target is Dividend per share >= $0.25 in FY26. | Intact | Dividend per share falls below $0.25 in FY26 | Dividend per share: $0.25 per share FY2026-Q1; GAAP. Published target: Dividend per share >= $0.25 in FY26. Target period is not explicitly aligned with this observation. Source published May 12, 20260.25 USD/share · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q1 · Period ending Mar 31, 2026 Source: company_financial_results. Reference: a05aa795-f6c7-44d0-a180-a90e5beeccd5. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Increase sales in 2026 | A primary condition in United-Guardian Inc's published investment case. The stated target is >=0% YoY revenue growth in FY26. | Intact | YoY revenue growth falls below 0% in FY26 | Revenue: $3.108M FY2026-Q2; GAAP. Published target: >=0% YoY revenue growth in FY26. Target and observation units differ. Source published Aug 11, 20263,108,267 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 58d4ff9a-79f1-49bb-9e95-2d367880d12f. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Revenue grew from $2.48M in 2025-Q1 to $2.87M in 2026-Q1 and from $2.84M in 2025-Q2 to $3.11M in 2026-Q2, reflecting 10-16% growth. Management's focus on expanding promotional efforts and market awareness aligns with this growth, indicating delivery on the stated priority. Delivery assessment Oct 24, 2026 |
Maintain valuation discount to peers | Its valuation is cheaper than peers with a P/E of 14.3 versus 17.5. | Intact | P/E rises above 17.5 sustainably | P/E (TTM): 12.32x As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 202612.3199 ratio · calculatedLast status assessment Oct 24, 2026Measurement sourceconsolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: UG:2026-10-23. Source status: canonical calculation. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
UG is a recent-performance-led business with a mildly favorable signal, rather than a clear turnaround or a proven durable compounder. Its long-term thesis is intact, though the evidence snapshot gives medium overall confidence and flags elevated risk.
The valuation evidence describes UG as cheap versus peers, with a negative expectations gap, meaning expectations appear less demanding than the model baseline. The priced-in assessment is tagged justified, with low fragility; the snapshot does not give enough detail to say exactly what operating assumptions the market expects.
Near term, management has delivered on its stated sales-growth priority, with reported revenue growth across the cited year-over-year quarters, and recently increased the dividend. The next guidance update and weakening jobs data are risks; the evidence does not provide enough detail to assess earnings quality beyond its neutral rating.
The unfavorable case is a guidance cut or further weakening in jobs data, which could pressure cyclical businesses and add to recession concerns. The favorable case depends partly on continued earnings strength and higher guidance from sector bellwethers, which could support sector momentum.
Over the next one to three years, UG’s thesis rests on continued sales execution and dividend support, while elevated risk makes guidance and the economic backdrop key swing factors. Recent performance supports an intact, mildly favorable view, but the evidence is limited. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.